ClinicalTrials.Veeva

Menu

Glycaemic Index of Fibre-rich Flours in Healthy Volunteers

P

Paulic Meunerie

Status

Completed

Conditions

Healthy

Treatments

Other: Experimental High-fiber bread
Other: Standard white bread
Other: Experimental white bread
Other: Standard High-fiber bread

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05372666
Qualista-IG

Details and patient eligibility

About

The project aims to evaluate the glycaemic index of breads from different types of flour. In particular, we aim to understand the glycaemic and insulin responses as well as satiety and sensory profiles of the products.

Enrollment

20 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Having a Body Mass Index (BMI) between 18.5 and 30 kg/m²
  • Non-smoker for more than three months
  • Having signed the informed consent form
  • Likely to follow the constraints generated by the study (one morning per week for 9 weeks)
  • Social insurance

Exclusion criteria

  • Pregnant woman
  • Subject with a known progressive somatic or psychiatric disease
  • Fasting blood glucose greater than 6.1 mmol/L (1.10 g/L), postprandial blood glucose greater than 7.7 mmol/L (1.4 g/L) or known diabetes treated or untreated
  • Hyperinsulinemia or a history of insulinoma
  • HbA1c greater than 7 %
  • History of hypercholesterolemia, hypertension, diabetes or glucose intolerance
  • History of food allergy or digestive pathology likely to affect digestion or absorption
  • Renal failure
  • ASAT or ALAT elevation beyond 1.5 times the upper limit
  • Subject consuming more than three glasses per day of alcohol or suffering from various addictions
  • Weight change of more than 3 kg in the last three months
  • Person participating in another clinical study, or in a period of exclusion from another study
  • Person deprived of liberty or under judicial protection

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

20 participants in 7 patient groups, including a placebo group

Control IG100
Placebo Comparator group
Description:
1 small bread loaf using T55 standard white flour for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Standard white bread
Reference WB
Experimental group
Description:
1 small bread loaf using T55 Qualista white flour for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Experimental white bread
Reference HFB
Active Comparator group
Description:
1 small bread loaf using T55 standard white flour supplemented with 11 % standard wheat bran (6% dietary fiber content) for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Standard High-fiber bread
Qualista HFB 01
Experimental group
Description:
1 small bread loaf using T55 Qualista white flour supplemented with 13 % untreated Qualista wheat bran (6% dietary fiber content) for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Experimental High-fiber bread
Qualista HFB 02
Experimental group
Description:
1 small bread loaf using T55 Qualista white flour supplemented with 13 % pretreated Qualista wheat bran (treatment A - 6% dietary fiber content) for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Experimental High-fiber bread
Qualista HFB 03
Experimental group
Description:
1 small bread loaf using T55 Qualista white flour supplemented with 13 % pretreated Qualista wheat bran (treatment B - 6% dietary fiber content) for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Experimental High-fiber bread
Qualista HFB 04
Experimental group
Description:
1 small bread loaf using T55 Qualista white flour supplemented with 13 % pretreated Qualista wheat bran (treatment C - 6% dietary fiber content) for a final content of 50 g equivalent digestible carbohydrates
Treatment:
Other: Experimental High-fiber bread

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems